CFO Dennis Mulroy sells 15,725 shares at $44.85 avg, reducing stake by 62.6%; stock up 28.4% in 30 days
Dennis Mulroy, Chief Financial Officer of AnaptysBio, executed 2 separate sales on 2025-12-16 totaling 15,725 shares (15.7K shares) for $705,332.78 ($705.3K), reducing his holdings from 25,126 shares (25.1K shares) to 9,401 shares (9.4K shares), a 62.6% reduction. The sales occurred at a blended average price of $44.85, near the current price of $47.53, which marks the 52-week high. This substantial liquidation follows a notable 30-day run of +28.4% and a 90-day surge of +128.1%, positioning the sale near the stock's peak valuation of the past year. While the company achieved strong fundamentals this quarter (Revenue $76,320,000.00 and Net income $15,113,000.00 with annual revenue growth of +432.0%), the full-year fiscal results were negative. The magnitude and timing of the CFO's exit warrants investor attention alongside monitoring of near-term operational performance.